Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 7, 2005International Journal of CancerOpen Access

Serum matrix metalloproteinase‐9 in head and neck squamous cell carcinomais a prognostic marker

View Full Paper
Ask AI
Bookmark
Share

Authors

HRHenni RuokolainenOulu University HospitalPPPaavo PääkköOulu University HospitalTTTaina Turpeenniemi‐HujanenOulu University Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ruokolainen et al. (2005) studied this question.

synapsesocial.com/papers/6a7e9050cb17bc2d1d0d209ehttps://doi.org/10.1002/ijc.21092
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Plasma MMP‐9 (92 kDa‐MMP) activity is useful in the follow‐up and in the assessment of prognosis in breast cancer patients2003 · 124 citations
  2. 2Enhanced Production of Matrix Metalloproteinase-2 in Human Head and Neck Carcinomas is Correlated with Lymph Node Metastasis2002 · 34 citations
  3. 3Nonparametric Estimation from Incomplete Observations1958 · 39,532 citations
  4. 4Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients2002 · 73 citations
  5. 5Analysis of Expression of Matrix Metalloproteinases-2 and −9 in Hypopharyngeal Squamous Cell Carcinoma by in Situ Hybridization1995 · 82 citations